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AbstrACt
Objectives Sleeve gastrectomy (SG) is the most 
frequently performed bariatric surgery procedure 
worldwide, but reports on long-term quality of life (QOL) 
outcomes are scarce. We investigated 5-year trajectories 
in QOL and their associations with weight loss after SG.
Design A prospective cohort study.
setting The study was conducted in a single Norwegian 
bariatric surgery centre.
Participants Out of 150 operated patients, 127 were 
included. Mean age was 41 years, 68% were women and 
the follow-up rate at 1 year was 85% and 64% at 1 and 
5 years, respectively.
Outcome measures Data were collected preoperatively, 
and 1 and 5 years after surgery assessing three different 
levels of QOL. The main exposure was weight loss after 
SG, assessed as per cent excess body mass index (kg/m2) 
loss (%EBMIL). The Obesity-Related Problem (OP) scale 
was used to measure obesity-specific health-related QOL 
(HRQOL). Physical (PCS) and mental (MCS) composite 
summary scores of the Short Form 36 Health Survey were 
used to capture generic HRQOL and Cantril Ladder was 
used to assess overall QOL.
results All HRQOL/overall QOL measures significantly 
improved at 1 year, followed by modest decline from 1 to 
5 years after surgery. Greater %EBMIL 5 years after surgery 
was significantly associated with improvements in OP and 
PCS scores, but not with MCS and Cantril Ladder scores. 
Although significant (p<0.001) and clinically relevant 
improvements in HRQOL/overall QOL outcomes were 
observed at 5 years, scores were still below the general 
population norms.
Conclusion Most patients undergoing SG experience 
substantial weight loss accompanied by statistically 
significant and clinically relevant long-term improvements 
in HRQOL/overall QOL. However, an important minority of 
patients still report low HRQOL/overall QOL 5 years after 
SG. Further research should aim to identify other factors 
that contribute to impaired QOL after bariatric surgery, 
even in the presence of successful weight control.
IntrODuCtIOn
Impaired quality of life (QOL) is a strong 
incentive for individuals with severe obesity 
to seek help for their condition. Thus, QOL 
is considered a main measure of treatment 
efficacy after bariatric surgery.1–4 The broad 
concept of QOL encompasses overall, generic 
and disease-specific QOL domains.
Sleeve gastrectomy (SG) is now the most 
frequently performed bariatric surgery 
procedure worldwide, and keeping the intes-
tines intact is regarded as a main advantage 
compared with other surgical methods.5 
Although associated with substantial short 
(1 year) and medium-term (2–3 years) 
improvements in a range of patient-reported 
outcomes, long-term (≥5 years) reports on 
QOL after SG are scarce.6–8
To the best of our knowledge, only one 
publication reports prospective long-term 
QOL data after SG.9 In a single-centre study, 
the obesity-specific Moorehead-Ardelt II 
(MAII) questionnaire and a visual analogue 
scale to represent overall QOL were used. 
The authors reported improvements in QOL 
until 2 years, followed by subsequent declines 
from 2 to 5 years after SG. Weight loss was 
not associated with either obesity-specific or 
overall QOL. The absence of a generic ques-
tionnaire precluded comparisons with QOL 
in the general population. Cross-sectional 
reports on generic QOL using the Short 
Form 36 Health Survey (SF-36) 5 years after 
strengths and limitations of this study
 ► This prospective 5-year study expands the limited 
knowledge of long-term quality of life outcomes and 
their association with weight loss after sleeve gas-
trectomy for severe obesity.
 ► By applying obesity-specific, generic and overall 
quality of life outcome measures, the impact of 
weight loss following sleeve gastrectomy on diverse 
life domains is assessed broadly.
 ► All long-term quality of life outcomes are compared 
with general population norms.
 ► The proportion of patients lost to follow-up at 5 years 
is a limitation. copyright.
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Figure 1 Patient flow chart from recruitment to 5-year 
follow-up.
SG are published.10–12 Comparing two similar cohorts of 
patients before and 5 years after surgery, we reported that 
mean SF-36 scores were significantly higher in the 5-year 
cohort than in the baseline cohort, although still below 
the general population norm.12 However, firm conclu-
sions on improvements in QOL cannot be drawn from 
cross-sectional studies alone and should rely on more 
than solely generic QOL measures.
Thus, the aim of this prospective study was to investigate 
long-term trajectories in QOL following SG, and to compare 
long-term QOL scores to those from the general popula-
tion. To avoid conceptual ambiguity, the broad term QOL 
was divided into three levels: (1) overall QOL representing 
satisfaction with life as a whole, (2) generic health-related 
QOL (HRQOL) representing broad domains of physical 
and mental health, and (3) obesity-specific HRQOL repre-
senting patients’ perception of QOL specifically related to 
their weight.13 Furthermore, we aimed to investigate associ-




The eligibility criteria for SG were a body mass index (BMI) 
≥40 kg/m2, or ≥35 kg/m2 with obesity-related comorbidi-
ties, age from 18 to 65 years and absence of active psychosis, 
alcohol or drug abuse. All eligible patients who under-
went SG from January 2010 to December 2013 at a single 
bariatric centre were recruited. Written informed consent 
was obtained at the preoperative outpatient visit. Preopera-
tive evaluation and follow-up were routinely performed by 
a multidisciplinary team including the surgeon, a dietitian 
and a nurse 3 months before surgery, and 3, 12, 24 and 60 
months postoperatively. Other healthcare professionals, 
such as a physiotherapist or psychologist were consulted 
as needed. Data were collected preoperatively, and during 
follow-up consultations 1 and 5 years after surgery.
Patient and public involvement
In line with requirements from the public funder of this 
research, patient involvement was ensured by discussing 
the initial study protocol with the national support group 
for people with overweight and obesity. The results will be 
disseminated to the study participants via newsletters and 
social media platforms after the study results are published.
the treatment: sleeve gastrectomy
Two surgeons performed the SG operations using a 32 
French tube as template for the resection, starting 1–2 cm 
proximal to the pylorus and ending at the cardia. The 
standardised technical procedure has been previously 
described.12 14
Demographics and clinical variables
Information on patients’ age, sex, marital/cohabitation 
status and educational level was recorded. Body weight 
was measured in light clothing without shoes to the 
nearest 0.1 kg, while height was measured in a standing 
position without shoes to the nearest 0.01 m. BMI was 
calculated as weight divided by height squared (kg/m2). 
Weight loss is presented as change in BMI (ΔBMI=ini-
tial BMI−postoperative BMI) and per cent excess BMI 
loss (%EBMIL=ΔBMI/(initial BMI−25)×100).15 We also 
report number of patients with more than 10 kg weight 
regain between 1 and 5 years16 and number of patients 
whose %EBMIL was below 50 at 5 years.17 Furthermore, 
we report number of patients whose BMI was below 
30 kg/m2 5 years after SG.18
Obesity-specific hrQOL
The Obesity-Related Problem (OP) scale, which captures 
obesity-specific psychosocial functioning in various daily life 
situations, was used to measure obesity-specific HRQOL. 
The questionnaire comprises eight items regarding (1) 
parties/social gatherings at home; (2) parties/social gather-
ings at a friend’s place; (3) going to restaurants; (4) partic-
ipating in organisations, attending courses, and so on; (5) 
going on vacations; (6) trying on and buying clothes; (7) 
bathing in public areas (swimming pools, beaches); and (8) 
sexual intercourse, intimate relations with partner. Patients’ 
statements range from 0 to 3: ‘definitely not bothered’ (0), 
‘not so bothered’ (1), ‘mostly bothered’ (2) and ‘definitely 
bothered’ (3). The summary raw total score is transformed 
to a standardised scale from 0 to 100, in which lower scores 
refer to higher degrees of psychosocial functioning. Scores 
below 20 indicate no or mild psychosocial impairment, 
from 20 to <40 mild impairment, from 40 to <60 moderate 
impairment, from 60 to <80 severe impairment and ≥80 
copyright.
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Table 1 Preoperative characteristics in patients with follow-up data at 5 years compared with patients lost to follow-up
All patients n=127
Available at follow-up  
(5 years) n=81 (64%)




Age (years) 41.4±12.6 41.0±12.5 42.2±12.9 0.589
Women, n (%) 86/127 (68%) 55/81 (67.9%) 31/46 (77.4%) 0.953
BMI (kg/m², mean±SD) 44.8±6.0 44.2±2.9 46.0±6.1 0.113
Superobese (BMI ≥50 kg/m2) 22/127 (17.3%) 12/81 (14.8%) 10/46 (21.7%) 0.322
Married/cohabitants, n (%) 74/127 (58.7%) 48/81 (59.3%) 26/45 (57.8%) 0.851
Higher education, n (%)* 32/125 (25.6%) 19/81 (23.4%) 13/44 (29.5%) 0.322
Anxiety (medically treated), n (%) 13/126 (10.3%) 7/80 (8.8%) 6/46 (13.0%) 0.446
Depression (medically treated), n 
(%)
24/127 (18.9%) 15/81 (18.5%) 9/46 (19.6%) 0.855
OP total (mean±SD) 63.2±24.6 62.7±25.3 64.0±23.6 0.421
MCS (mean±SD) 42.9±10.8 43.0±10.8 42.6±11.0 0.458
PCS (mean±SD) 38.4±8.8 39.0±8.7 37.3±9.0 0.458
Cantril's Ladder (mean±SD) 4.9±1.8 5.0±1.8 4.8±1.8 0.697
*Higher education = ≥3 years at university/college. χ2 test was performed for comparing categorical variables. Independent t-test was 
performed for comparing continuous variables. Differences were considered statistically significant if p≤0.05.
BMI, body mass index;Cantril's Ladder, overall quality of life; MCS, mental composite summary score; OP total, Obesity-Related Problem 
scale total score; PCS, physical composite summary score.
extreme impairment.19 In addition to the OP total score, 
we report responses to the eight individual items. The OP 
has been translated and validated for Norwegian bariatric 
patients.20
Generic hrQOL
The SF-36 was used to measure generic HRQOL. This is 
a widely used HRQOL instrument, also recommended 
as the generic measure of choice in obesity research.21 22 
It contains 36 items with eight subscales regarding (1) 
physical functioning, (2) physical role, (3) bodily pain, 
(4) general health, (5) vitality, (6) social functioning, 
(7) emotional role functioning, and (8) mental health.23 
Herein we use the two SF-36 summary scores based 
on factor analysis with oblique rotation; that is, phys-
ical composite summary (PCS) and mental composite 
summary (MCS). The PCS and MCS cluster the eight 
subscales according to common physical and mental attri-
butions. Each of the two summary components is assessed 
on a transformed scale where higher scores represent 
better physical or mental HRQOL.23 The SF-36 is psycho-
metrically validated for use in Norwegian patients with 
severe obesity.24
Overall QOL
Cantril Ladder, containing one item, has been widely 
used in various populations and in different settings 
and is considered a valid and reliable measure of overall 
QOL.20 25 26 Respondents were asked to think of a ladder 
numbered from 0 to 10, with the best possible life being 10, 
and the worst possible life being 0. They were then asked 
to rate the perception of their own current lives on one of 
the steps between 0 and 10. A score of 6 or more is labelled 
‘high life satisfaction’ and less than 6 ‘low life satisfaction’.
General population scores on hrQOL and overall QOL
For comparison, HRQOL and overall QOL values repre-
senting the general population were obtained from 
three different data sets. Population scores on the OP 
scale were derived from a randomly selected Swedish 
sample (n=1.017) with a BMI <30.27 Population scores on 
SF-36 (n=5.396)28 and data representing Cantril Ladder 
(n=6.129)29 were derived from two randomly selected 
Norwegian samples including all BMI categories.
statistical analyses
Continuous variables are presented as means±SD or 95% 
CIs. Categorical variables are presented as counts and 
percentages (%). Available patients at 5-year follow-up 
and patients lost to follow-up were compared for baseline 
differences.
An a priori power calculation was performed based 
on previous changes observed in HRQOL from baseline 
to 5 years after biliopancreatic diversion with duodenal 
switch (BPDDS) surgery.30 With an expected n=120, 
power=90% and p=0.05 we could discover a statistically 
significant change equal to 0.30 SD (two-sided paired 
t-test). Expected change was >0.76 SD.
The BMI values, OP scale, QOL, SF-36 MCS and SF-36 
PCS scores were all modelled using longitudinal regres-
sion models with time as a (categorical) explanatory 
variable, a hetereoscedastic error structure (different 
variances at each time point) and an unstructured correla-
tion matrix. These models use data from all patients, 
even patients with partially missing data, reducing poten-
tial bias introduced by non-random loss to follow-up. 
The models were fitted using generalised least squares by 
the ‘nlme’ R package.31 For testing changes in single OP 
copyright.











pen: first published as 10.1136/bm






4 Flølo TN, et al. BMJ Open 2019;9:e031170. doi:10.1136/bmjopen-2019-031170
Open access 
Table 2 Comparisons of mean QOL scores/BMI values 
at baseline, 1 year and 5 years after sleeve gastrectomy 
(n=127)*





Baseline 127 45 6 44 to 46
1 year† 125 30 5 29 to 31
5 years‡ 103 32 6 31 to 33
OP
Baseline 127 63 25 59 to 67
1 year† 110 21 21 18 to 25
5 years‡ 81 31 28 25 to 36
Effect size 1.3
SF-36 MCS
Baseline 123 43 11 41 to 45
1 year† 108 53 9 51 to 55
5 years‡ 78 48 12 45 to 50
Effect size 0.3
SF-36 PCS
Baseline 123 38 9 37 to 40
1 year† 108 52 8 51 to 54




Baseline 121 4.9 1.8 4.6 to 5.2
1 year† 109 7.4 1.6 7.1 to 7.7
5 years‡ 72 6.4 1.9 5.9 to 6.8
Effect size 0.8
*All estimates, CIs and p values are based on longitudinal models, that 
is, on the joint distribution of measurements/responses from all three 
time points (stratified by questionnaire/method).
†All p values for differences in mean scores for 1 and 5 years 
compared with baseline were <0.001.
‡All p values for differences in mean scores for 5 years compared with 
1 year were <0.001.
BMI, body mass index; MCS, mental composite summary score; OP, 
Obesity-Related Problem scale; PCS, physical composite summary 
score; QOL, quality of life; SF-36, Short Form 36 Health Survey.
items, we used paired t-tests, not adjusted for multiple 
comparisons.
To assess whether the OP total score, SF-36 (MCS and 
PCS) and Cantril Ladder at 5 years were associated with 
%EBMIL from baseline to 5 years, or could be predicted by 
baseline variables, we fitted four unadjusted and adjusted 
linear regression models. The following covariates were 
included: age, sex, baseline BMI, the corresponding base-
line HRQOL/overall QOL score of the dependent vari-
able and %EBMIL from baseline to 5 years.
For handling missing data, we used multiple imputation 
(200 imputations), based on predictive mean matching. 
This was done with the ‘aregImpute()’ function in the 
‘rms’ R package,32 with default arguments. The variables 
used in the imputation models were the ones included in 
the regression models.
Population norms for SF-36 and Cantril Ladder were 
adjusted by age and gender to reflect the same distribu-
tion as in our study sample. The method for this adjust-
ment has been described elsewhere.33 For the OP score, 
the published average non-obese population score was 
used; 58% were women and age ranged from 37 to 
61 years.19 The one-sample t-test was used to compare the 
study sample with the population norms.
Clinical relevance of changes in patient-reported 
outcomes over time was defined by calculating the mean 
difference in HRQOL/overall QOL between two time 
points divided by the pooled SD, using Cohen’s d for 
effect size (ES) ([M2–M1]/SD baseline). These ES were 
judged according to general criteria: trivial (<0.2), small 
(0.2 to <0.5), moderate (0.5 to <0.8) and large (≥0.8).34 
Cohen’s cut-offs are in accordance with findings from a 
range of study populations suggesting that a difference 
of 0.5 SD in HRQOL outcomes, either at individual or 
at group level, most likely is clinically relevant. Smaller 
ES may also be important.35 Hence, these criteria also 
guided the assessments of clinically relevant differences 
in HRQOL/overall QOL between the present cohort at 
5 years and population norms.
Statistical significance was set to p≤0.05. Analyses were 
performed using R V.3.5.136 and Statistical Package for 
Social Sciences for Windows, V.23.0 (SPSS).
The Strengthening the Reporting of Observational 
Studies in Epidemiology cohort reporting checklist was 
used according to BMJ open’s author guidelines.37
resuLts
sample characteristics
During the recruitment period, 150 patients under-
went SG. Twenty-three patients were later excluded as 
study participants; 22 because patient-reported data were 
missing at all time points due to administrative mistakes, 
and one patient died of reasons unrelated to the SG. Of 
the 127 included SG patients (mean age 41±13 years, 
68% women), complete follow-up data were available for 
85% and 64% of the patients at 1 and 5 years, respectively 
(figure 1). No statistically significant differences were seen 
in preoperative characteristics between patients available 
and lost to follow-up at 5 years postoperatively (table 1).
Change in bMI
On average, a significant decrease in BMI occurred from 
baseline to 1 year, followed by a subsequent modest, but 
statistically significant increase from 1 to 5 years after 
surgery (table 2). Mean %EBMIL was 76 (95% CI 72 to 
80) and 64 (95% CI 59 to 70) after 1 and 5 years, respec-
tively, and weight loss corresponding to %EBMIL ≥50 was 
seen in 73/103 (71%) patients at 5 years after SG. Highest 
observed %EBMIL at 5 years was 125 and the lowest was 
−18. Forty of 103 (39%) evaluable patients obtained a 
copyright.
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Figure 2 Mean scores with 95% CIs for the eight Obesity-Related Problem (OP) scale items at baseline, 1 year and 5 years 
(n=127*). *The number of responses differed by time point and questions: 122–127 at baseline, 105–110 at 1 year and 79–81 at 
5 years.
BMI <30 kg/m2 after 5 years, and 38/103 (37%) patients 
gained ≥10 kg from 1 to 5 years postoperatively.
Changes in obesity-specific hrQOL
Significant improvement in mean OP scores occurred 
from baseline to 1 year, followed by a subsequent modest, 
but statistically significant, decline from 1 to 5 years after 
surgery (table 2). The improvement in the OP total score 
from baseline to 5 years was statistically significant with an 
ES of 1.3.
Preoperatively, 61% of the patients reported extreme or 
severe psychosocial impairment in all daily life activities 
(OP total score ≥60). One year after surgery, extreme or 
severe impairment was reported by 6% of the patients, and 
by 16% after 5 years. Four patients (5%) reported higher 
psychosocial impairment 5 years after SG compared with 
their preoperative status.
Scores on each of the eight daily life situations covered 
by the OP largely improved from baseline to 1 year 
(p<0.001) (figures 2 and 3, table 3). From 1 to 5 years, 
there were small, but significant declines (p≤0.05) for all 
situations, except for ‘bathing in public areas’ (p=0.58) 
and ‘sexual intercourse/intimate situations’ (p=0.22). 
The greatest improvement was seen for ‘trying on and 
buying clothes’, with 67% of patients reporting this activity 
to be ‘definitely bothersome’ preoperatively, compared 
with 9% at 5 years postoperatively. Patients who obtained 
a BMI <30 kg/m2 at 5 years after SG reported significantly 
higher psychosocial functioning (ie, mean OP total) than 
did patients with a BMI ≥30 kg/m2 (20 vs 35, mean differ-
ence 15, 95% CI 3.8 to 26.1, p=0.01), yet still significantly 
below the population norm (mean difference 11.5, 95% 
CI 3.7 to 19.4, p=0.005). Mean OP total score at 5 years 
was 20.6 (95% CI 14.7 to 26.6; p<0.001) points higher (ie, 
poorer psychosocial functioning) in the present cohort 
than in the population norm.19 This difference corre-
sponds to an ES of 0.7.
Changes in generic hrQOL
Significant improvements on mean PCS and MCS scores 
occurred from baseline to 1 year, followed by a subse-
quent modest, but significant decline from 1 to 5 years 
after surgery (table 2, figure 4). Nevertheless, improve-
ments from baseline to 5 years were statistically significant 
for both domains with an ES of 0.9 and 0.44 for PCS and 
MCS, respectively. Mean PCS and MCS scores at 5 years in 
the present cohort were 4.9 (95% CI 2.3 to 7.6; p<0.001) 
and 4.2 (95% CI 1.5 to 6.9; p=0.003) points lower (ie, 
poorer), respectively, than in the population norm.28 
These differences correspond to ES of 0.4 and 0.3, respec-
tively. Patients who obtained a BMI <30 kg/m2 at 5 years 
after SG reported significantly higher PCS scores than 
did patients with a BMI ≥30 kg/m2 (50.9 vs 44.1, mean 
difference 6.8, 95% CI 1.7 to 12.1, p=0.01). There was no 
significant difference in MCS scores in the two groups of 
patients.
Changes in overall QOL
Significant improvement in the Cantril Ladder mean 
score occurred from baseline to 1 year, followed by a subse-
quent modest, but significant decline from 1 to 5 years 
after surgery (table 2). The improvement from baseline 
to 5 years was still statistically significant (p<0.001) with an 
ES of 0.8. Low overall QOL (Cantril Ladder score <6) was 
reported by 67% of the patients preoperatively, compared 
with 13% and 32% of the patients at 1 and 5 years after 
SG, respectively. The mean Cantril Ladder score at 5 years 
was 1.5 (95% CI 1.1 to 2.0; p<0.001) points poorer in the 
present cohort than the population norm,29 equivalent 
to an ES of 0.8. There was no significant difference in 
overall QOL at 5 years in patients who obtained a BMI 
copyright.
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Figure 3 Individual changes in Obesity-Related Problem 
(OP) items from baseline to 5 years (n=81*). The response 
options were 0 (‘definitely not bothered’), 1 (‘not so 
bothered’), 2 (‘mostly bothered’) and 3 (‘definitely bothered’). 
The height of each bar is proportional to the number of 
patients with the corresponding response, and the width of 
the ends of each flow line is proportional to the number of 
patients with the given response pattern. *Only patients who 
answered the questionnaire at both time points are included, 
and the number of patients varied between 75 and 81 
(depending on the question).
<30 kg/m2 at 5 years after SG compared with patients with 
a BMI ≥30 kg/m2.
Associations between weight loss and hrQOL/overall QOL
In the adjusted regression models with OP, MCS, PCS and 
Cantril Ladder scores at 5 years as dependent variables, 
the baseline HRQOL/overall QOL variables predicted 
OP, MCS and PCS, but not Cantril Ladder at 5 years. In 
addition, baseline BMI predicted OP score, but none of 
the other HRQOL/overall QOL outcome measures at 
5 years. According to the adjusted model, the OP score 
increases by on average 1.7 points (95% CI 0.6 to 2.7) for 
each baseline additional BMI point. The OP total score 
decreased by on average 29.2 points (95% CI 8.7 to 49.8) 
for each additional %EBMIL between baseline and 5 years 
(table 4). Moreover, %EBMIL at 5 years was significantly 
associated with OP and PCS scores, but not with MCS and 
Cantril Ladder after 5 years. The adjusted values for R2, 
contributed by all variables together, on OP total score 
and PCS were 0.36 and 0.29, respectively.
DIsCussIOn
Principal findings and comparisons with other studies
In this prospective 5-year study of patients undergoing 
SG, we observed statistically significant and clinically 
meaningful improvements in all levels of QOL (ie, obesi-
ty-specific and generic HRQOL, and overall QOL) from 
before SG to 5 years after the procedure. In terms of 
weight loss, the average BMI dropped significantly and 
markedly during the first year with a subsequent modest 
regain in BMI occurring at 5 years. A corresponding 
pattern was seen for all QOL measures demonstrating 
significant mean improvements at 1 year, followed by a 
slight decline from 1 to 5 years postoperatively. Adjusted 
regression analyses showed that preoperative BMI signifi-
cantly predicted OP score at 5 years, and that %EBMIL 
from baseline to 5 years was significantly associated with 
both OP and PCS scores 5 years after SG. Although signifi-
cantly improved, mean total scores on both obesity-spe-
cific, generic HRQOL and overall QOL outcomes in the 
current study were below the general population norms 
5 years after SG.
The purpose of our study was to expand the limited 
knowledge on long-term changes in disease-specific and 
generic HRQOL, as well as overall QOL after SG. To our 
knowledge, only one study on long-term obesity-specific 
HRQOL and overall QOL after SG has been published, 
but the use of different questionnaires hampers direct 
comparison of HRQOL/overall QOL outcomes.9 In the 
study of Charalampakis et al, the time-dependent changes 
in weight and obesity-specific HRQOL/overall QOL were 
mainly consistent with findings in the current paper. 
Furthermore, our results on changes in HRQOL are in 
accordance with previous reports on long-term trajectories 
following BPDDS and Roux-en-Y gastric bypass (RYGBP) 
as measured by the OP scale and/or SF-36.22 38–41 Specif-
ically, Karlsson et al reported changes in OP total score 
from before to 10 years after RYGBP corresponding to 
an ES of 1.0, compared with 1.3 in the current study, that 
is, large clinically relevant improvements.38 Aasprang et al 
reported mean MCS and PCS, as measured by the SF-36, 
at 5 years after BPDDS nearly identical to the current 
study, also with small to moderate ES for improvements.40 
Long-term HRQOL scores were significantly below the 
population norm in both studies. Furthermore, Kolotkin 
et al compared HRQOL changes between RYGBP and 
non-surgery patients at 6 years using the obesity-specific 
Impact of Weight on Quality of Life-Lite (IWQOL-Lite) 
questionnaire and SF-36.39 For the RYGBP group, large 
and significant improvements in both obesity-specific and 
generic HRQOL (PCS only) were seen from baseline to 
6 years; nonetheless, PCS scores at 6 years were below US 
norms and IWQOL-Lite total score was below a non-obese 
community reference group. Overall, there seem to be 
copyright.
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Table 3 Comparison of mean scores on individual items in the OP scale, at baseline, 1 year and 5 years after sleeve 
gastrectomy (n=127)
Respondents Mean SD 95% CI P value*
OP 1: Parties/social gatherings at home
  Baseline 127 1.5 1.0 1.4 to 1.7 –
  1 year 110 0.4 0.7 0.3 to 0.6 <0.001
  5 years 81 0.6 0.8 0.4 to 0.8 0.01
OP 2: Parties/social gatherings at a friend’s place
  Baseline 127 1.9 1.0 1.7 to 2.1 –
  1 year 110 0.5 0.8 0.3 to 0.6 <0.001
  5 years 81 0.8 1.0 0.6 to 1.0 0.002
OP 3: Going to restaurants
  Baseline 127 1.6 1.0 1.4 to 1.8 –
  1 year 109 0.6 0.9 0.4 to 0.8 <0.001
  5 years 81 0.8 0.9 0.6 to 1.0 0.05
OP 4: Participating in organisations, attending courses, and so on
  Baseline 125 1.6 1.0 1.5 to 1.8 –
  1 year 109 0.4 0.7 0.3 to 0.5 <0.001
  5 years 80 0.6 0.9 0.4 to 0.9 0.002
OP 5: Going on vacation
  Baseline 127 1.7 1.0 1.5 to 1.9 –
  1 year 110 0.4 0.7 0.3 to 0.5 <0.001
  5 years 81 0.7 0.9 0.5 to 0.9 <0.001
OP 6: Trying on and buying clothes
  Baseline 127 2.5 0.8 2.4 to 2.7 –
  1 year 110 0.6 0.9 0.4 to 0.7 <0.001
  5 years 81 1.0 1.0 0.8 to 1.2 <0.001
OP 7: Bathing in public areas (swimming pools, beaches)
  Baseline 127 2.5 0.9 2.3 to 2.6 –
  1 year 108 1.3 1.1 1.1 to 1.5 <0.001
  5 years 80 1.4 1.2 1.1 to 1.6 0.58
OP 8: Sexual intercourse, intimate situations
  Baseline 122 1.8 1.0 1.6 to 2.0 –
  1 year 105 0.9 1.0 0.7 to 1.1 <0.001
  5 years 79 1.0 1.1 0.8 to 1.3 0.22
*P value for change in mean score from previous time point (only based on respondents with data from both time points). The p values for 
change from baseline to 5 years are not listed, but are all <0.001.
OP, Obesity-Related Problem scale.
remarkable similarities in the pattern of long-term 
changes in HRQOL across different bariatric surgery 
procedures (gastric banding, BPDDS, RYGBP and SG), 
outcome measures and countries.22
Several researchers have suggested a dose–response 
correlation between change in weight and HRQOL.38 39 42 
In the present cohort, weight loss at 5 years after surgery 
was significantly associated with perceived obesi-
ty-specific HRQOL at 5 years. Although most patients 
reported severe to extreme psychosocial impairment 
before the operation, their reports after 1 year improved 
significantly. As weight regain occurred, the proportion 
of patients reporting severe impairment again increased. 
The clear association between %EBMIL and OP indicates 
that the patients’ perception of obesity-specific HRQOL 
is particularly sensitive to changes in BMI. Similar results 
were also reported by Karlsson et al for patients with 
10-year follow-up after RYGBP.38 In addition, Kolotkin et 
al reported that percentage excess weight loss at 6 years 
for RYGBP patients correlated significantly with changes 
in the IWQOL-Lite total score and PCS, but not MCS.39 
This close association may, however, not hold true for 
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Figure 4 Individual scores for the Short Form 36 Health 
Survey (SF-36) mental (MCS) and physical (PCS) composite 
summary scores (n=123*). Each point corresponds to a single 
patient. The mean score is marked with horizontal lines. The 
Norwegian general population norm is marked with a yellow 
horizontal line. *The number of patients was 123 at baseline, 
108 at 1 year and 78 at 5 years, for both PCS and MCS.
all levels of HRQOL, as weight loss at 5 years was signifi-
cantly associated only with PCS at 5 years and not MCS 
in our study. Of note, in their study on 5-year outcomes 
after SG, Charalampakis et al found no such correlations 
of weight loss and obesity-specific HRQOL, as measured 
by the MAII questionnaire.9 Furthermore, Aasprang et al 
found no significant correlations between weight loss and 
MCS and PCS using the SF-36 in their 10-year study after 
BPDDS.40
As the terms HRQOL/overall QOL encompass 
diverse life domains, one could expect a disparity in the 
influential power of weight loss on different aspects of 
life. Along these lines, we report no statistically signif-
icant associations between weight loss and broader 
QOL domains, such as overall QOL. In fact, a recent 
cross-sectional study on generic and obesity-specific 
HRQOL 4 years after bariatric surgery, controlling 
for a number of other variables that may affect QOL, 
questions the importance of weight loss as the main 
determinant of improvements in all levels of QOL after 
surgery.43 For a more accurate assessment of the rela-
tionship between surgically induced weight loss and 
QOL it appears important to differentiate between 
narrow QOL concepts, related specifically to constraints 
and concerns associated with changes of weight, and 
the broader aspects of QOL. The latter may to a larger 
degree be influenced by other weight-independent 
factors. Furthermore, despite profound weight loss in a 
majority of patients we report a noteworthy difference 
in all aspects of QOL compared with the population 
norm, suggesting that weight loss alone may be overem-
phasised in terms of improving patients’ lives. In clin-
ical practice, this calls for patient care that centres on 
other important determinants of QOL than weight loss 
alone.
strengths and limitations
Along with the prospective design and long-term follow-up, 
the present study reports broad measures of QOL covering 
overall, generic and disease-specific domains relative to 
general population scores. To our knowledge this has not 
been presented after SG before. We cannot rule out other 
factors that could possibly modify the observed relation-
ships of preoperative weight, weight loss and HRQOL/
overall QOL, such as comorbidities, stressful life events 
and eating disorders. For example, redundant skin has 
been reported as an important determinant of poorer 
psychosocial functioning and generic HRQOL after 
RYGBP.44 No systematic assessment of excessive skin and 
the degree to which this was a concern for the patients 
was done in the present cohort.
The proportion of patients lost to follow-up at 5 years 
represents a limitation. High attrition rates are common 
in longitudinal bariatric surgery research, comparable 
to the follow-up rate of 64% in the present study.8 45 
However, there were no significant baseline differences 
in registered traits comparing patients attending the 
5-year follow-up after SG and those missing. By using 
multiple imputation, any bias caused by missing data is 
reduced.
Implications and suggestions for future research
Significant and meaningful long-term improvements in 
HRQOL/overall QOL after bariatric surgery appear to be 
consistently reported. Particularly, improved psychosocial 
functioning as measured by the OP scale may considerably 
enhance patients’ performance in daily life situations. Still, 
the trend towards weight regain and concurrent decline in 
HRQOL/overall QOL after initial postoperative improve-
ments remains a concern. This underscores obesity as a 
refractory chronic condition. Though limited, some knowl-
edge exists about factors that may promote or hinder main-
tenance of weight loss.46 47 Hence, postoperative support 
may be of crucial importance to maintain successful short 
or medium-term outcomes after bariatric surgery. Several 
studies have emphasised associations between thorough 
long-term follow-up programmes and endured weight 
management.48–51 As weight control appears particularly 
important for patients’ perceived psychosocial functioning 
in daily life situations, as reported herein, deciphering 
copyright.
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components of successful weight maintenance programmes 
after surgery seems mandatory. Also, our results emphasise 
that the magnitude of weight loss does not equally influence 
all aspects of HRQOL and overall QOL. Properly distrib-
uted, this knowledge should help bariatric surgery patients 
to form realistic expectations for their well-being as a result 
of weight loss alone. Further research should aim to iden-
tify coexisting factors that may contribute to impaired QOL 
before and after bariatric surgery and address the effect of 
novel interventions to support both long-term weight loss 
maintenance and HRQOL/overall QOL after surgery.
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